In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Kasia Averall, Head of Clusters at Cell and Gene Therapy Catapult.

In the podcast, they discuss a range of topics affecting the life sciences sector in the UK, from how to ensure your lab space is built and designed for innovation to thrive to the challenges in future-proofing a facility without knowing what the future may be. They also explore the requirements needed for GMP manufacturing space versus your traditional R&D space, and how you meet the regulatory requirements which accompany this.